Monotherapy of anti-PD-1 mAb, anti-PD-L1 mAb, anti-Tim-3 mAb, and anti-Lag-3 mAb led to a significantly higher cytotoxicity of tumor antigen specific CTL clones against GC cells as compared to no treatment control. This evidence concerns the gene PDCD1 and neoplasm.